Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
INNV Catalyst Timeline
Dated clinical, regulatory and corporate events for InnovAge Holding Corp. Common Stock
Past FDA Catalysts and PDUFA Decisions
How INNV actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Drug Pipeline Intelligence
No drug pipeline
InnovAge Holding Corp. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every INNV program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| DAMATO NICOLEOfficer (CHIEF LEGAL OFFICER) | Sell | -23,814 304,897 held | $8.70 | 09/25/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in INNV
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| Redmile Group, LLC | 0.3 % | 17.98 M | 843.58 K | -0.76% ( -6.42 K) |
INNV Institutional Ownership Trends
INNV Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How INNV ranks across every disease it competes in
INNV News
InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026
InnovAge Holding Corp. will release its fiscal first quarter 2027 financial results on November 3, 2026, after market close. A conference call to discuss these results will take place at 5 p.m. E.T. The company emphasizes its commitment to providing comprehensive healthcare programs for frail seniors through the PACE model.
Read more →InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders
InnovAge Holding Corp. has announced a secondary offering of 10 million shares of common stock priced at $9.25 each, set to close on September 24, 2026. The offering is conducted by selling stockholders affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe. InnovAge will not receive proceeds from the sale but will cover associated costs.
Read more →InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders
InnovAge Holding Corp. has announced a secondary public offering of 10 million shares of its common stock by affiliated investment funds. The company will not receive any proceeds from this sale but will cover associated costs. The offering is being managed by Barclays, Goldman Sachs, and Wells Fargo, and is part of a registration statement filed with the SEC.
Read more →InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026
InnovAge Holding Corp. reported strong financial results for the fiscal year ending June 30, 2026, with total revenues rising to $989.7 million, a 15.9% increase from the previous year. The company significantly reduced its net loss to $0.7 million, down from $35.3 million in 2025. Looking forward, InnovAge provided optimistic financial guidance for Fiscal Year 2027, aiming to enhance its services for seniors.
Read more →InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference
InnovAge Holding Corp. will announce its fiscal fourth quarter and full year financial results on September 8, 2026. A conference call will follow at 5 p.m. E.T. Additionally, the company will participate in the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, at 8:00 AM E.T., with live webcasts available for both events.
Read more →InnovAge Appoints Jennifer Browne as President and Chief Operating Officer
InnovAge has appointed Jennifer Browne as President and Chief Operating Officer, effective June 8, 2026. With extensive experience in value-based healthcare, Browne's leadership is expected to enhance InnovAge's performance and compliance. She will focus on operational execution, participant experience, and scaling services to reach more seniors. The appointment reflects InnovAge's commitment to sustainable growth and improving care for older adults.
Read more →INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2025
InnovAge Holding Corp. reported financial results for the fiscal third quarter ending March 31, 2026, highlighting a 15.5% increase in total revenues to $251.9 million. Despite the revenue growth, the company faced a net loss of $29.9 million compared to a loss of $11.1 million in the same period last year. InnovAge is raising its fiscal 2026 revenue and Adjusted EBITDA guidance, reflecting confidence in future performance improvements driven by recent investments. The overall financial performance shows a mixture of growth in revenues and increased losses, indicating areas for potential concern.
Read more →Proven Senior Care Model Takes Center Stage at the Capitol
InnovAge Holding Corp. met with Colorado lawmakers to advocate for the PACE program, emphasizing its effectiveness in providing comprehensive care for seniors. Seniors shared their positive experiences, highlighting the program's role in maintaining independence and reducing hospitalizations. InnovAge leaders stressed the need for awareness and support for PACE amidst budget discussions.
Read more →INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2025
InnovAge Holding Corp. announced its financial results for the fiscal second quarter ended December 31, 2025, reporting significant improvement in its operating performance. The company achieved total revenues of $239.7 million, up by 14.7% compared to the previous year, alongside a turnaround from a loss to a net income of $11.8 million. Adjusted EBITDA also saw substantial growth, reaching $22.2 million. InnovAge maintains its focus on ensuring sustainable growth and improving healthcare outcomes for its participants.
Read more →InnovAge Expands Board with Appointment of Two Directors
InnovAge Holding Corp. has expanded its Board of Directors by appointing Pavithra Mahesh and Sean Traynor. Both directors bring extensive experience and institutional knowledge, with Mahesh serving on the Quality and Compliance Committee and Traynor on the Compensation, Nominating and Governance Committee. This expansion aims to strengthen InnovAge's strategic direction and enhance its PACE model for senior care.
Read more →InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026
InnovAge Holding Corp. will release its fiscal second quarter 2026 financial results on February 3, 2026, after market close. A conference call will follow at 5 p.m. E.T. to discuss the results. The company focuses on providing comprehensive healthcare programs for frail seniors through its PACE model, emphasizing quality care and cost reduction.
Read more →InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
InnovAge Holding Corp. announced its participation in the 44th Annual J.P. Morgan Healthcare Conference, where CEO Patrick Blair will present on January 12, 2026. The event will be webcast live, allowing broader access to the company's insights and strategies. InnovAge focuses on providing comprehensive healthcare programs for frail seniors, emphasizing quality care and cost reduction.
Read more →INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2025
InnovAge Holding Corp. announced strong financial results for the first quarter of fiscal 2026, reporting total revenues of $236.1 million, a 15.1% increase from the same period last year. The company achieved net income of $7.7 million, reversing a net loss from the previous year. Adjusted EBITDA also showed significant growth, up to $17.6 million, reflecting improved operational efficiency. InnovAge continues to focus on expanding its services and enhancing care for frail seniors through its PACE program.
Read more →INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2025
InnovAge Holding Corp. reported its financial results for the fourth quarter and fiscal year ending June 30, 2025. The company achieved a total revenue of $853.7 million, reflecting an 11.8% increase from the previous year. However, it also reported a significant increase in net loss, rising to $35.3 million, compared to $23.2 million in the prior year. Looking forward, InnovAge issued guidance for fiscal year 2026, estimating expected census and revenue growth, although potential external factors may affect actual performance.
Read more →INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2024
InnovAge Holding Corp. has announced its financial results for the fiscal second quarter ended December 31, 2024, revealing a total revenue of $209 million, which represents a 10.6% increase from the previous year. Despite this growth, the company reported a significant net loss of $13.5 million, a steep increase from $3.8 million a year earlier. The company's contribution margin improved, but the adjusted EBITDA decreased compared to the prior year. Overall, while revenue growth shows promise, the increased losses raise concerns regarding financial sustainability.
Read more →INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2024 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the first fiscal quarter ending September 30, 2024, reporting total revenues of $205.1 million, a notable increase from the previous year. The company achieved a 50.6% improvement in its loss before income taxes, which decreased to $5.3 million, and its adjusted EBITDA increased significantly to $6.5 million. However, InnovAge still experienced a net loss of $5.7 million, down from $11 million a year prior. The press release also highlighted increases in their participant census and encouraged investors to note upcoming financial guidance while acknowledging potential external uncertainties.
Read more →Document InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services DENVER
InnovAge has appointed Michael Scarbrough as the new President and Chief Operating Officer and Maria Lozzano as President of Pharmacy Services, effective November 4, 2024. Scarbrough's extensive experience in healthcare is expected to support InnovAge's strategic goals, while Lozzano's promotion is aimed at enhancing pharmacy operations and participant experiences. The transition follows the departure of former COO Christine Bent, who is thanked for her service.
Read more →INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2024 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the fourth quarter and fiscal year ending June 30, 2024. The company reported a year-over-year revenue increase of approximately 11% to $763.9 million, while also improving its net loss to $23.2 million from $43.6 million in the prior year. As part of a commitment to operational excellence, InnovAge expressed confidence in its financial performance and outlined ambitious growth plans for the upcoming fiscal year. The company anticipates an increase in participant census and revenue in FY 2025, indicating a positive outlook.
Read more →INNOVAGE HOLDING CORP. ANNOUNCES $5.0
InnovAge Holding Corp. has announced a $5.0 million share repurchase program, approved by its Board of Directors. The initiative allows the company to buy back its common stock from the open market or through other designated means, depending on various conditions. InnovAge emphasizes a commitment to improving senior care while maintaining a strategic approach to shareholder value by repurchasing shares. The company currently serves around 6,820 participants across 20 centers.
Read more →